Gene Regulation
Negative Feed-forward Control of Tumor Necrosis Factor (TNF) by Tristetraprolin (ZFP36) Is Limited by the Mitogen-activated Protein Kinase Phosphatase, Dual-specificity Phosphatase 1 (DUSP1): IMPLICATIONS FOR REGULATION BY GLUCOCORTICOIDS*

https://doi.org/10.1074/jbc.M115.697599Get rights and content
Under a Creative Commons license
open access

TNF is central to inflammation and may play a role in the pathogenesis of asthma. The 3′-untranslated region of the TNF transcript contains AU-rich elements (AREs) that are targeted by the RNA-binding protein, tristetraprolin (also known as zinc finger protein 36 (ZFP36)), which is itself up-regulated by inflammatory stimuli, to promote mRNA degradation. Using primary human bronchial epithelial and pulmonary epithelial A549 cells, we confirm that interleukin-1β (IL1B) induces expression of dual-specificity phosphatase 1 (DUSP1), ZFP36, and TNF. Whereas IL1B-induced DUSP1 is involved in feedback control of MAPK pathways, ZFP36 exerts negative (incoherent) feed-forward control of TNF mRNA and protein expression. DUSP1 silencing increased IL1B-induced ZFP36 expression at 2 h and profoundly repressed TNF mRNA at 6 h. This was partly due to increased TNF mRNA degradation, an effect that was reduced by ZFP36 silencing. This confirms a regulatory network, whereby DUSP1-dependent negative feedback control reduces feed-forward control by ZFP36. Conversely, whereas DUSP1 overexpression and inhibition of MAPKs prevented IL1B-induced expression of ZFP36, this was associated with increased TNF mRNA expression at 6 h, an effect that was predominantly due to elevated transcription. This points to MAPK-dependent feed-forward control of TNF involving ZFP36-dependent and -independent mechanisms. In terms of repression by dexamethasone, neither silencing of DUSP1, silencing of ZFP36, nor silencing of both together prevented the repression of IL1B-induced TNF expression, thereby demonstrating the need for further repressive mechanisms by anti-inflammatory glucocorticoids. In summary, these data illustrate why understanding the competing effects of feedback and feed-forward control is relevant to the development of novel anti-inflammatory therapies.

Background:

ZFP36 negatively regulates AU-rich element-containing mRNAs.

Results:

DUSP1 silencing increases ZFP36 expression and enhances negative feed-forward control of TNF.

Conclusion:

MAPK inhibition initially attenuates TNF mRNA, but reduced feed-forward control subsequently produces an increase.

Significance:

Understanding such networks is essential to develop novel anti-inflammatory therapies or understand TNF repression by glucocorticoids, which may not require DUSP1 or ZFP36 expression.

dual-specificity phosphoprotein phosphatase
glucocorticoid
inflammation
mitogen-activated protein kinase (MAPK)
tumor necrosis factor (TNF)
anti-inflammatory
DUSP1
feed-forward control

Cited by (0)

*

This research was supported by Canadian Institutes of Health Research Grants MOP 68828 and 125918 (to R. N.) and by Lung Association of Alberta and the North West Territories and University of Calgary Studentships (to S. S.). Real-time PCR was performed by virtue of an equipment and infrastructure grant from the Canadian Fund for Innovation and the Alberta Science and Research Authority. Work in the laboratory of R. N. was also supported by grants from AstraZeneca and GlaxoSmithKline. The authors declare that they have no conflicts of interest with the contents of this article.

3

R. Newton, M. M. Mostafa, C. F. Rider, E. M. King, S. Shah, C. Dumonceaux, S. Traves, M. M. Kelly, A. Miller-Larsson, and R. Leigh, unpublished data.